BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 2552004)

  • 1. Immunoblot analysis of the antibody response to murine cytomegalovirus in genetically resistant and susceptible mice.
    Farrell HE; Shellam GR
    J Gen Virol; 1989 Oct; 70 ( Pt 10)():2573-86. PubMed ID: 2552004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice.
    Lawson CM; Grundy JE; Shellam GR
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1987-98. PubMed ID: 2841411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed-type hypersensitivity responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice.
    Lawson CM; Grundy JE; Shellam GR
    J Gen Virol; 1987 Sep; 68 ( Pt 9)():2379-88. PubMed ID: 2821177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral antibody response to individual viral proteins after murine cytomegalovirus infection.
    Selgrade MK; Huang YS; Graham JA; Huang CH; Hu PC
    J Immunol; 1983 Dec; 131(6):3032-5. PubMed ID: 6315823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse cytomegalovirus infection induces antibodies which cross-react with virus and cardiac myosin: a model for the study of molecular mimicry in the pathogenesis of viral myocarditis.
    Lawson CM; O'Donoghue HL; Reed WD
    Immunology; 1992 Mar; 75(3):513-9. PubMed ID: 1315309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of interferon induction in mice of resistant and susceptible strains during murine cytomegalovirus infection.
    Allan JE; Shellam GR
    J Gen Virol; 1985 May; 66 ( Pt 5)():1105-12. PubMed ID: 2582082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to cardiac myosin in mouse cytomegalovirus myocarditis.
    O'Donoghue HL; Lawson CM; Reed WD
    Immunology; 1990 Sep; 71(1):20-8. PubMed ID: 2170269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against murine cytomegalovirus infection by passive transfer of neutralizing and non-neutralizing monoclonal antibodies.
    Farrell HE; Shellam GR
    J Gen Virol; 1991 Jan; 72 ( Pt 1)():149-56. PubMed ID: 1846643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple autoantibodies following cytomegalovirus infection: virus distribution and specificity of autoantibodies.
    Bartholomaeus WN; O'Donoghue H; Foti D; Lawson CM; Shellam GR; Reed WD
    Immunology; 1988 Jul; 64(3):397-405. PubMed ID: 2842252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of cyclosporin on major histocompatibility complex-linked resistance to murine cytomegalovirus.
    Lawson CM; Hodgkin PD; Shellam GR
    J Gen Virol; 1989 May; 70 ( Pt 5)():1253-9. PubMed ID: 2543779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of cytomegalovirus infection. Distribution of viral products, immune complexes and autoimmunity during latent murine infection.
    Olding LB; Kingsbury DT; Oldstone MB
    J Gen Virol; 1976 Nov; 33(2):267-80. PubMed ID: 186563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically determined resistance to lethal murine cytomegalovirus infection is mediated by interferon-dependent and -independent restriction of virus replication.
    Quinnan GV; Manischewitz JF
    J Virol; 1987 Jun; 61(6):1875-81. PubMed ID: 3033318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of neutralizing monoclonal antibodies to murine cytomegalovirus.
    Farrell HE; Shellam GR
    J Gen Virol; 1990 Mar; 71 ( Pt 3)():655-64. PubMed ID: 2155998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominant utilization of V beta 8+ T cell receptor genes in the H-2Ld-restricted cytotoxic T cell response against the immediate-early protein pp89 of the murine cytomegalovirus.
    Rodewald HR; Koszinowski UH; Eichmann K; Melchers I
    J Immunol; 1989 Dec; 143(12):4238-43. PubMed ID: 2556481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in murine cytomegalovirus replication in fibroblasts from different mouse strains in vitro: correlation with in vivo resistance.
    Harnett GB; Shellam GR
    J Gen Virol; 1982 Sep; 62 (Pt 1)():39-47. PubMed ID: 6290595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic control of mouse cytomegalovirus-induced myocarditis.
    Lawson CM; O'Donoghue H; Bartholomaeus WN; Reed WD
    Immunology; 1990 Jan; 69(1):20-6. PubMed ID: 2155871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine cytomegalovirus.
    Schilt U
    Immunobiology; 1987 Jan; 174(1):10-9. PubMed ID: 3032777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cytolytic T lymphocyte response to the murine cytomegalovirus. I. Distinct maturation stages of cytolytic T lymphocytes constitute the cellular immune response during acute infection of mice with the murine cytomegalovirus.
    Reddehase MJ; Keil GM; Koszinowski UH
    J Immunol; 1984 Jan; 132(1):482-9. PubMed ID: 6317749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
    Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
    J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cell dependent within-host competition arises during multiple MCMV infection: consequences for viral transmission and evolution.
    McWhorter AR; Smith LM; Masters LL; Chan B; Shellam GR; Redwood AJ
    PLoS Pathog; 2013 Jan; 9(1):e1003111. PubMed ID: 23300458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.